MDM2 Overexpression Modulates the Angiogenesis-Related Gene Expression Profile of Prostate Cancer Cells
Authors:
- Thiagarajan VenkatesanTVThiagarajan Venkatesan
- Ali AlaseemAAAli Alaseem
- Aiyavu ChinnaiyanACAiyavu Chinnaiyan
- Sivanesan DhandayuthapaniSDSivanesan Dhandayuthapani
- Thanigaivelan KanagasabaiTKThanigaivelan Kanagasabai
- Khalid AlhazzaniKAKhalid Alhazzani
- Priya DondapatiPDPriya Dondapati
- Saad AlobidSASaad Alobid
- Umamaheswari NatarajanUNUmamaheswari Natarajan
- Ruben SchwartzRSRuben Schwartz
- Appu RathinaveluAppu Rathinavelu
Open Access
Abstract
The Murine Double Minute 2 (MDM2) amplification or overexpression has been found in many tumors with high metastatic and angiogenic ability. Our experiments were designed to explore the impact of MDM2 overexpression, specifically on the levels of angiogenesis-related genes, which can also play a major role in tumor propagation and increase its metastatic potential. In the present study, we have used the human angiogenesis RT2 profiler PCR array to compare the gene expression profile between LNCaP and LNCaP-MST (MDM2 transfected) prostate cancer cells, along with LNCaP-MST cells treated with Nutlin-3, an MDM2 specific inhibitor. As a result of the overexpression of MDM2 gene in LNCaP-MST (10.3-fold), Thrombospondin 1 (THBS1), Tumor necrosis factor alpha (TNF-α) and Matrix metallopeptidase 9 (MMP9) were also found to be significantly up-regulated while genes such as Epiregulin (EREG), Tissue inhibitor of metalloproteinases 1 (TIMP1) were down-regulated. Also, we determined the total MMP activity and MMP9 expression in LNCaP, LNCaP-MST and SJSA-1 cells. Our results indicated that MDM2 level is positively correlated with MMP activity and MMP9 secretion. Our findings offer strong supporting evidence that MDM2 can impact growth and metastatic potential of cancer cells through tilting the balance towards pro-angiogenic mechanisms.Keywords
This publication has 41 references indexed in Scilit:
- MDM2 Promotes Invasion and Metastasis in Invasive Ductal Breast Carcinoma by Inducing Matrix Metalloproteinase-9PLOS ONE, 2013
- The Mdm2–p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressorGenes & Development, 2010
- The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversityBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2010
- Identification of HDM2 as a regulator of VEGF expression in cancer cellsLife Sciences, 2008
- AP‐2α and AP‐2γ regulate tumor progression via specific genetic programsThe FASEB Journal, 2008
- Detection of HDM2 and VEGF co-expression in cancer cell lines: novel effect of HDM2 antisense treatment on VEGF expressionLife Sciences, 2007
- Mdmx as an essential regulator of p53 activityBiochemical and Biophysical Research Communications, 2005
- Signalling pathways of the TNF superfamily: a double-edged swordNature Reviews Immunology, 2003
- Inhibition of melanoma growth and metastasis by combination with (−)‐epigallocatechin‐3‐gallate and dacarbazine in miceJournal of Cellular Biochemistry, 2001
- EpiregulinJournal of Biological Chemistry, 1995